SAN DIEGO--(BUSINESS WIRE)--Conquering the last frontier for monitoring vital signs, Brain Tunnelgenix Technologies Corp.™ (btt™ Corp.) is introducing the Abreu btt™ 700 System for continuous temperature monitoring at the Annual Meeting of the American Society of Anesthesiologists (ASA) today. The Abreu btt 700 System sensor is approved by the U.S. Food and Drug Administration for placement on the skin and to be used during surgical procedures, recovery room, intensive care and general patient monitoring. The Abreu btt 700 System can be seen at the btt Corp. booth (3815) at the ASA today through October 18.
